Effects of Prokineticins on Cerebral Cell Function and Blood–Brain Barrier Permeability
International Journal of Molecular Sciences · 21.10.2023 · 24 (20) · 15428
DOI: 10.3390/ijms242015428 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.10.2023. Verfasst von Hadi Younes und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Grenoble-Alpes, CEDEX 9, 38043 Grenoble, France. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Blood-Brain Barrier. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Grenoble Alps, Grenoble Alliance for Integrated Structural & Cell Biology of University Grenoble Alpes, GRAL, the Grenoble Alliance for Integrated Structural & Cell Biology of University Grenoble Alpes.
Abstract (Originalsprache)
Prokineticins are a family of small proteins with diverse roles in various tissues, including the brain. However, their specific effects on different cerebral cell types and blood–brain barrier (BBB) function remain unclear. The aim of this study was to investigate the effects of PROK1 and PROK2 on murine cerebral cell lines, bEnd.3, C8.D30, and N2a, corresponding to microvascular endothelial cells, astrocytes and neurons, respectively, and on an established BBB co-culture model. Western blot analysis showed that prokineticin receptors (PROKR1 and PROKR2) were differentially expressed in the considered cell lines. The effect of PROK1 and PROK2 on cell proliferation and migration were assessed using time-lapse microscopy. PROK1 decreased neural cells’ proliferation, while it had no effect on the proliferation of endothelial cells and astrocytes. In contrast, PROK2 reduced the proliferation of all cell lines tested. Both PROK1 and PROK2 increased the migration of all cell lines. Blocking PROKRs with the PROKR1 antagonist (PC7) and the PROKR2 antagonist (PKR-A) inhibited astrocyte PROK2-mediated migration. Using the insert co-culture model of BBB, we demonstrated that PROKs increased BBB permeability, which could be prevented by PROKRs’ antagonists.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Grenoble-Alpes, CEDEX 9, 38043 Grenoble, France.
- Commissariat à l'Energie Atomique et aux Energies Alternatives (CEA), Laboratory of Biology & Biotechnology for Health, Interdisciplinary Research Institute of Grenoble, 38000 Grenoble, France.
- Institut National de la Santé et de la Recherche Médicale U1292, Biologie et Biotechnologie pour la Santé, 38000 Grenoble, France.
ORCID-Profile: Mohamed Benharouga, Nadia Alfaidy, Christel Marquette
Förderung
- University of Grenoble Alps
- Grenoble Alliance for Integrated Structural & Cell Biology of University Grenoble Alpes
- GRAL, the Grenoble Alliance for Integrated Structural & Cell Biology of University Grenoble Alpes
- internal funds
Zitieren
APA
Younes, H., Kyritsi, I., Mahrougui, Z., Benharouga, M., Alfaidy, N., & Marquette, C. (2023). Effects of Prokineticins on Cerebral Cell Function and Blood–Brain Barrier Permeability. International Journal of Molecular Sciences, 24(20), 15428. https://doi.org/10.3390/ijms242015428
Vancouver
Younes H, Kyritsi I, Mahrougui Z, Benharouga M, Alfaidy N, Marquette C. Effects of Prokineticins on Cerebral Cell Function and Blood–Brain Barrier Permeability. International Journal of Molecular Sciences. 2023;24(20):15428. doi:10.3390/ijms242015428
BibTeX
@article{Younes2023,
author = {Younes, Hadi and Kyritsi, Ioanna and Mahrougui, Zineb and Benharouga, Mohamed and Alfaidy, Nadia and Marquette, Christel},
title = {Effects of Prokineticins on Cerebral Cell Function and Blood–Brain Barrier Permeability},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {20},
pages = {15428},
doi = {10.3390/ijms242015428}
}
EUVIMED